| 摘要 |
<p>This invention is directed to compounds of formula (1) and their pharmaceutically acceptable salts, wherein R?1, R2, and R3¿ are as defined herein; intermediates for the synthesis of such compounds; and methods of using such compounds in the treatment of nicotine addiction/withdrawal and CNS disorders.</p> |
